Aryl Butenes Active Against K562 Cells and Lacking Tyrosinase Inhibitory Activity as New Leads in the Treatment of Leukemia

Mini-Reviews in Medicinal Chemistry - United Arab Emirates
doi 10.2174/1389557517666170208142254

Related search